Metabolic therapy in children with hypotensive type of autonomic dysfunction syndrome
Background. Trimetabol is a combined appetite stimulant that has cardioprotective, neurotropic and antioxidant effects. The purpose was to evaluate the effectiveness of metabolic therapy with the use of Trimetabol in children with hypotensive type of autonomic dysfunction syndrome. Materials and methods. Forty five children aged 9–17 years with autonomic hypotensive dysfunction were examined. All children were divided into two groups: the main group (n = 30) received Trimetabol, the comparison group (n = 15) — multivitamins. The course of treatment was 1 month. Results. Against the background of treatment with Trimetabol, headache, dizziness, heart pain decreased, appetite, heart rhythm and conduction normalized. Unlike the comparison group, the children of the main group experienced better dynamics of ambulatory blood pressure monitoring (ABPM) and heart rate variability. According to ABPM, average daily systolic blood pressure (SBP) increased from 107.4 ± 1.0 mmHg to 110.8 ± 1.1 mmHg, p < 0.05 (in the comparison group, it has not changed significantly), the time index of hypotension of SBP decreased from 36.3 ± 2.9 % to 25.4 ± 2.6 %, p < 0.01 (in the comparison group — from 40.7 ± 4.7 % to 26.8 ± 4.6 %, p < 0.05). Reduction in total spectrum power was observed in both groups, but in the main group, it was more significant and occurred as a result of a decrease in VLF% (from 75.82 ± 1.63 % to 69.50 ± 1.70 %, p < 0.05), and due to an increase in the specific gravity of LF (from 8.78 ± 0.43 % to 10.20 ± 0.37 %, p < 0.05) and HF% (from 11.31 ± 0.46 % to 13.90 ± 0.80 %, p < 0.05). These data indicate that under the influence of Trimetabol, the central and autonomic regulation circuit activity was redistributed from the decrease in the activity of the central circuits (VLF%) and the relative increase in the activity of autonomic circuits (LF%, HF%). Conclusions. Trimetabol is an effective drug for the treatment of hypotensive type of autonomic dysfunction. The use of Trimetabol improves metabolic processes in the myocardium, normalizes the autonomic regulation of the cardiac rhythm and blood pressure and is safe for adolescents.
Full Text:PDF (Українська)
Luk'ianova EM, Kvashnina LV, Rodionov VP. Clinical study of the efficacy and tolerability of Trimetabol in children of primary school age during the period of adaptation to systematic education. Zbirnik naukovih pracʹ spivrobitnikiv NMAPO imeni P.L. Supika. 2008;17(3):124-130. (in Russian).
Rodionov V. Disorders of appetite in children and the possibility of its correction. Z turbotoju pro dytynu. 2011;(1):18-19. (in Russian).
Majdannyk VG, Smijan OI, Bynda TP, Savelieva-Kulyk NO. Vegetatyvni dysfunkcii' u ditej: navchal'nyj posibnyk [Vegetative dysfunctions in children: a training manual]. Sumy: SumDU; 2014. 186 p. (in Ukrainian).
Antipkin IuG, Omelchenko LI, Kvashnyna LV. Application of Trimetabol in pediatric practice. Liky Ukrai'ny. 2008;(1):53-56. (in Ukrainian).
Kvashnina LV, Rodionov VP, Makovkina YuA, Matviychuk VV. Metabolic bases of optimization of motor modes for younger schoolboys during physical trainings at school. Perinatologiya i pediatriya. 2008;(34):100-102. (in Russian).
Krasaelap A, Madani S. Cyproheptadine: a potentially effective treatment for functional gastrointestinal disorders in children. Pediatr Ann. 2017 Mar 1;46(3):e120-e125. doi: 10.3928/19382359-20170213-01.
Merhar SL, Pentiuk SP, Mukkada VA, Meinzen-Derr J, Kaul A, Butler DR. A retrospective review of cyproheptadine for feeding intolerance in children less than three years of age: effects and side effects. Acta Paediatr. 2016. Aug;105(8):967-70. doi: 10.1111/apa.13477.
Balykova LA, Ivianskii SA, Shirokova AA, Urziaeva AN, Shchekina NV. Changes in the cardiovascular and immune systems in young athletes: the positive effects of L-carnitine. Pediatriia. Consilium medicum. 2014;(4):20-24. (in Russian).
Nyan'kovskyi SL, Dobrik OO, Іs'kiv MYu. Metabolic therapy and its role in the complex treatment of connective tissue dysplasia in pediatric nephrology. Sovremennaya pediatriya. 2016;(73):131-136. doi: 10.15574/SP.2016.73.131. (in Russian).
Marushko YV, Hyschak TV, Khomych OV. The content of N-terminal brain natriuretic peptide and exercise tolerance in children with secondary cardiomyopathy and correction of the change agents by the "Ahvantar". Sovremennaya pediatriya.2015;(66):62-66. doi 10.15574/SP.2015.65.62. (in Russian).
Barrett JS, Hirankarn S, Holford N, et al. A hemodynamic model to guide blood pressure control during deliberate hypotension with sodium nitroprusside in children. Front Pharmacol. 2015 Jul 28;6:151. doi: 10.3389/fphar.2015.00151.
Dadambaev ET, Sarbasova ZhO, Aitkalieva AO, Akhmedzhanova KB, Altybaeva GA. The use of trimetabol in the treatment of children with hypotrophy in the outpatient setting. Zdorov'e i bolezn'. 2011;(102):104-105. (in Russian).
Rodionov VP. Disorders of appetite in children and the possibility of its correction. Z turbotoju pro dytynu. 2011;(1):18-19. (in Russian).
Kvashnina LV, Rodionov VP. Bad appetite in children: myth or reality? Mystectvo likuvannia. 2009;(2):23-25. (in Russian).
Ostroukhova IP, Rychkova TI, Vasil'eva TM, Kulikova EV. Energotropic therapy of children with autonomic dysfunction. In: Proceeding of the XVI Congress of pediatricians of Russia with international participation on Actual problems of pediatrics. 2012, February 24-27; Moscow, Russian Federation. Moscow; 2012. 547 p. (in Russian).
Litovchenko TA, Zinchenko YeK. Arterial hypоtension - initial stage of chronic cerebral circulation insufficiency (peculiarities of treatment). Meždunarodnyj nevrologičeskij žurnal. 2011;(6):70-74. (in Russian).
Copyright (c) 2018 CHILD`S HEALTH
This work is licensed under a Creative Commons Attribution 4.0 International License.
© Publishing House Zaslavsky, 1997-2019